GlobeNewsWire
24 Jun 2026, 19:37 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
C-Sept PRO is achieving a high gross margin of approximately 72%. — High-margin product lines significantly improve bottom-line profitability and overall company valuation.
+0.60C-Sept PRO sales are accelerating, with monthly revenue rising from an average of $93,000 to over $108,000 over the last three months. — Positive growth momentum and repeat ordering patterns suggest scalable and sustainable revenue growth.
+0.40Cosmos Health plans to expand its hospital-focused antiseptics business into additional European markets. — Expansion into new geographic markets increases the total addressable market and long-term growth potential.
+0.30Continue reading
6 related stories
Top 1 mover · tap to explore
C-Sept PRO is on track for annualized sales of over $1.3 million, contributing approximately $0.9 million in annualized gross profit. — While concrete, the absolute dollar amount is relatively small compared to the scale of typical NASDAQ listed companies.
Which stocks this story touches
The company is reporting accelerating sales, high gross margins (72%), and successful market adoption of its C-Sept PRO product.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
2h ago
